Online ISSN: 2582-6387
IP Journal of Surgery and Allied Sciences (JSAS) open access, peer-reviewed quarterly journal publishing since 2019 and is published under the Khyati Education and Research Foundation (KERF), is registered as a non-profit society (under the society registration act, 1860), Government of India with the vision of various accredited vocational courses in healthcare, education, paramedical, yoga, publication, teaching and research activity, with the aim of faster and better dissemination of knowledge, we will be publishing the article ‘Ahead more...Review Article
Author Details :
Volume : 2, Issue : 3, Year : 2020
Article Page : 81-88
https://doi.org/10.18231/j.jsas.2020.013
Abstract
Depression is a common mental disorder that presents with depressed mood, loss of interest or pleasure,
decreased energy, feelings of guilt or low self-worth, disturbed sleep or appetite, and poor concentration.
Depression shall become the second largest illness in terms of morbidity by another decade. 50-65% of
patients respond to the first antidepressant. No particular antidepressant agent is superior to another in
efficacy or time to response. Depression is less prevalent among older adults than among younger adults
but can have serious consequences. Choice can be guided by matching patients’ symptoms to side effect
profile, presence of medical and psychiatric co morbidity. The adequate treatment of residual symptoms
following an acute depressive episode, including insomnia symptoms, may prevent relapse. In the near
future, developments are likely to remain focused on monoamine neurotransmitters, with the aim of finding
agents that are either more effective, better tolerated or that have a faster onset of action than existing
options.
Keywords: Depression, Tricyclics, SSRI, SNRI, MAOI.
How to cite : Chaudhry S, Depression and its Dilemma. IP J Surg Allied Sci 2020;2(3):81-88
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.